However, a 12‐week MICT‐based intervention in CAD patients was found to result in a significant reduction in circulating CRP and IL‐1 concentrations, contrary to what we observed in our patient population (Goldhammer et al., 2005). This evidence concerns the gene IL1B and coronary artery disorder.